Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   

NIDA Home > Publications > Director's Reports > May, 2009 Index    

Director's Report to the National Advisory Council on Drug Abuse - May, 2009



Extramural Policy and Review Activities

Receipt, Referral, and Review

NIDA received 1106 applications, including both primary and dual assignments, for which the Office of Extramural Affairs (OEA) managed the programmatic referral process during this Council cycle. Of these, NIDA received the primary assignment on 883 applications.

OEA arranged and managed 18 grant review meetings in which 294 applications were evaluated. OEA's reviews included applications in chartered, standing review committees and Special Emphasis Panels (SEPs). In addition, OEA's Contracts Review Branch (CRB) arranged and managed 17 contract proposal review meetings.

NIDA's chartered committees consist of NIDA-E (Treatment Review Committee), NIDA-F (Health Services Review Committee), NIDA-L (Medications Development Committee), and NIDA-K (Training Committee). In addition to meetings of each of these committees, OEA staff held 14 Special Emphasis Panels to review grant applications for a variety of reasons:

Conflicts with the chartered committees
Program Project grant applications
Cutting-Edge Basic Research Awards (CEBRA)
Behavioral Science Track Award for Rapid Transition (B/START)
Imaging Science Track Award for Research Transition (I/START)
Conference Grants (R13)
Mechanism for Time-Sensitive Research Opportunities
Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24)
Requests for Applications (RFAs)

OEA managed the following RFA reviews:

  • DA09-001 - Medications Development for Cannabis-Related Disorders (R01)
  • DA09-002 - Medications Development Centers of Excellence (P50)
  • DA09-003/004 - Functional Characterization of Genetic Variants and Interactions: The Genes, Environment and Health Initiative (R21 & R03)
  • DA09-005 - Pilot Clinical Trials of Pharmacotherapies for Substance Related Disorders (R01)
  • DA09-007 - The Interaction of HIV, Drug Use, and the Criminal Justice System (R01)

Completed contract-related review activity from the Contracts Review Branch since the last Council includes:

R&D and non-R&D Contract Reviews

  • N01DA-9-7770 - NIDA Center for Genetic Studies
  • N01DA-9-8889 - Medication Discovery Using Rat Models of Relapse
  • N01DA-9-8890 - Analytical Chemistry and Stability Testing of Treatment Drugs
  • N01DA-9-1204 - National Hispanic Science Network
  • N01DA-9-1140 - Educational Marketing
  • N01DA-9-2217 - Data and Statistics Center for the CTN

Phase II SBIR Contract Reviews

  • N44DA-9-2214 - Development of Web-Based Training
  • N44DA-9-2215 - Just Ask: Web-Based SBIRT Support
  • N44DA-9-2216 - Web-Based Skills Training for SBIRT
  • N44DA-9-7764 - Use of I/M Cross-Section and m/z as a Unique Identifier of Lipids and Neuropeptides in Complex Biosamples
  • N44DA-9-8874 - Novel Azetidine CB1 Antagonists
  • N44DA-9-8869 - Long Acting Buprenorphine for Opiate Maintenance

Phase I SBIR Contract Reviews

  • N43DA-9-7768 - Screening, Characterization and Validation Assays for Protein Capture Reagents
  • N43DA-9-7769 - Tool Development for New or Improved Capture Reagents
  • N43DA-9-5542 - Rapid Assessment Tools for Sexual and Drug Use Risk Behaviors
  • N43DA-9-1138 - Development of Science Education Materials or Programs
  • N43DA-9-5541 - Instrument Development

CTN Data and Safety Monitoring Board(s) Meetings

  • January 21, 2009 to discuss the study proposal CTN 0037, Exercise as a Treatment for Substance Use Disorders.
  • February 12, 2009 to discuss the study proposal CTN 0044 - Web-delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders.
  • March 27, 2009 to discuss the progress of study protocols CTN 0027: Starting Treatment with Agonist Replacement Therapies (START) and CTN 0031, Stimulant Abuser Groups to Engage in 12-Step (STAGE-12) and the final study results of study protocol CTN 0014 Brief Strategic Family Therapy for Adolescent Drug Abusers (BSFT).

Certificates of Confidentiality

Between December 5, 2008 and March 6 2009, OEA processed 68 Certificate applications, including 19 amendments for either extension of expiration date or protocol change.

Staff Training and Development

The OEA Symposium Series, a forum for staff training and sharing of ideas and information, continued to provide open forums for discussions and presentations that included Enhancing Peer Review updates, Checklist training (type 5 review and approval process in IMPAC - PGM) and a talk on NIH/NSF collaborations.


Index

Research Findings

Program Activities

Extramural Policy and Review Activities

Congressional Affairs

International Activities

Meetings and Conferences

Media and Education Activities

Planned Meetings

Publications

Staff Highlights

Grantee Honors



Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal